Latch Medical is pleased to announce that the team will be exhibiting at Pharmapack Europe on January 21–22, 2026, in Paris, France. The event brings together leading innovators in drug delivery and device development, providing an ideal platform to share progress on the Pharmalatch Platform.

The Pharmalatch Hollow (PLH) is a medical device for intradermal injection of liquid formulations. It is designed to accurately deliver to the skin, control the intradermal injection procedure through device geometry rather than user technique—ensuring consistent needle insertion depth and reduced variability—and to be compatible with existing drug formulations and doses without requiring reformulation.

Across the two days, the team will present new data demonstrating the platform’s ability to deliver precise, reliable intradermal administration through device-driven control of needle depth. Attendees will also have the opportunity to learn more about the ongoing development of the PLH device and its potential role within future intradermal delivery strategies.

Visitors are invited to meet the team at Stand S18, where representatives will be available to discuss current research, development milestones, and collaboration opportunities. To arrange a meeting in advance, please contact peter.nicholson@latch-medical.com.

The PLH product is currently in development, pre-approval, and not for sale in the USA, EU, or any other jurisdiction.